Clinical trial for Type 1 Diabetes
Official title C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
ClinicalTrials.gov ID: NCT07807280
What this study is testing
- What it's testing
- The goal of this randomized study is to learn whether a CGM-guided insulin dosing education program can help adults with diabetes improve how they dose mealtime insulin. The main question it aims to answer is: 1\.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults 18 years of age or older.
- Diagnosis of diabetes for at least 1 year.
- Currently using or willing to start using a continuous glucose monitor (CGM).
- Currently using multiple daily insulin injections (MDI).
- HbA1c ≥8% at screening/baseline.
You likely can't join if
- Use of an insulin pump or automated insulin delivery system.
- Significant medical, cognitive, or psychiatric condition that, in the investigator's judgment, would interfere with participation or completion of...
- Pregnancy or plans to become pregnant during the study period.
- Current participation in another treatment study that could affect diabetes management or study outcomes.
- Inability/unwillingess to independently use a CGM device or administer insulin.
- Any other condition that, in the investigator's judgment, would make participation inappropriate or interfere with the study's objectives.
See the full eligibility criteria
- Adults 18 years of age or older.
- Diagnosis of diabetes for at least 1 year.
- Currently using or willing to start using a continuous glucose monitor (CGM).
- Currently using multiple daily insulin injections (MDI).
- HbA1c ≥8% at screening/baseline.
- Does not routinely use carbohydrate counting or demonstrates poor/inconsistent carbohydrate counting for mealtime insulin dosing.
- Able and willing to participate in the study visits and intervention sessions.
- Able to provide informed consent.
- Use of an insulin pump or automated insulin delivery system.
- Significant medical, cognitive, or psychiatric condition that, in the investigator's judgment, would interfere with participation or completion of study procedures. Limited life expectancy that would prevent completion...
- Pregnancy or plans to become pregnant during the study period.
- Current participation in another treatment study that could affect diabetes management or study outcomes.
- Inability/unwillingess to independently use a CGM device or administer insulin.
- Any other condition that, in the investigator's judgment, would make participation inappropriate or interfere with the study's objectives.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.